Abstract:Perturbation of huntingtin (HTT)'s physiological function is one postulated pathogenic factor in Huntington's disease (HD). However, little is known how HTT is regulated in vivo. In a proteomic study, we isolated a novel ~40kDa protein as a strong binding partner of Drosophila HTT and demonstrated it was the functional ortholog of HAP40, an HTT associated protein shown recently to modulate HTT's conformation but with unclear physiological and pathologic roles. We showed that in both flies and human cells, HAP40 maintained conserved physical and functional interactions with HTT. Additionally, loss of HAP40 resulted in similar phenotypes as HTT knockout. More strikingly, HAP40 strongly affected HTT's stability, as depletion of HAP40 significantly reduced the levels of endogenous HTT protein while HAP40 overexpression markedly extended its half-life. Conversely, in the absence of HTT, the majority of HAP40 protein were degraded, likely through the proteasome. Further, the affinity between HTT and HAP40 was not significantly affected by polyglutamine expansion in HTT, and contrary to an early report, there were no abnormal accumulations of endogenous HAP40 protein in HD cells from mouse HD models or human patients. Lastly, when tested in Drosophila models of HD, HAP40 partially modulated the neurodegeneration induced by full-length mutant HTT while showed no apparent effect on the toxicity of mutant HTT exon 1 fragment. Together, our study uncovers a conserved mechanism governing the stability and in vivo functions of HTT and demonstrates that HAP40 is a central and positive regulator of endogenous HTT. Further, our results support that mutant HTT is toxic regardless of the presence of its partner HAP40, and implicate HAP40 as a potential modulator of HD pathogenesis through its multiplex effect on HTT's function, stability and the potency of mutant HTT's toxicity.

Regulation of intracellular HAP1 trafficking.

HAP40 is a conserved central regulator of Huntingtin and a specific modulator of mutant Huntingtin toxicity

HAP1 and intracellular trafficking.

Huntingtin-associated Protein 1-Associated Intracellular Trafficking in Neurodegenerative Diseases

Regulation of Intracellular Trafficking of Huntingtin-Associated Protein-1 is Critical for TrkA Protein Levels and Neurite Outgrowth

Interaction of Huntingtin-associated Protein-1 with Kinesin Light Chain: Implications in Intracellular Trafficking in Neurons.

Huntingtin Interacting Proteins and Pathological Implications

14-3-3 Protein Interacts with Huntingtin-Associated Protein 1 and Regulates Its Trafficking

A Huntingtin-Associated Protein Enriched in Brain with Implications for Pathology

Huntingtin Functions As A Scaffold for Selective Macroautophagy

Essential sequence of the N-terminal cytoplasmic localization-related domain of huntingtin and its effect on huntingtin aggregates

The Cellular and Subcellular Localization of Huntingtin-Associated Protein 1 (hap1): Comparison with Huntingtin in Rat and Human

Interaction of Huntingtin-Associated Protein with Dynactin P150Glued

Expression of Huntingtin-Associated Protein-1 in Neuronal Cells Implicates a Role in Neuritic Growth.

Impaired Α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Trafficking and Function by Mutant Huntingtin

Huntingtin contains an ubiquitin-binding domain and regulates lysosomal targeting of mitochondrial and RNA-binding proteins

A huntingtin-HAP1-PCM1 pathway in ciliogenesis.

HAP40 is a conserved central regulator of Huntingtin and a potential modulator of Huntington's disease pathogenesis

HAP40 modulates mutant Huntingtin aggregation and toxicity in Huntington's disease mice

Preferential accumulation of N-terminal mutant huntingtin in the nuclei of striatal neurons is regulated by phosphorylation.

Subcellular Clearance and Accumulation of Huntington Disease Protein: A Mini-Review.